University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new ...

The tool is said to predict “off-target” effects for seven drugs that could aid in cellular hypertrophy prevention.

Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by ...

Over 30 million Americans take antidepressants. Researchers found four specific types with ties to cognition loss later in ...

Sales of antidepressants in Russia during the period of January-February 2025 amounted to 2.8 billion roubles ($30 million) ...

Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...

Researchers hope their findings help doctors prescribe antidepressants "that are better adapted for patients with dementia." ...

New study shows dementia patients who are on antidepressants, especially selective serotonin reuptake inhibitors (SSRIs), over time may experience faster cognitive decline.

Garcia Ptacek and the team observed large differences in how various antidepressants affected cognitive function. Escitalopram, a commonly used SSRI, was associated with the most rapid cognitive ...